News
Colchicine before PCI for acute MI fails to improve major outcomes
March 17, 2021
In STEMI patients scheduled for PCI, preprocedural colchicine fails to improve outcomes in the randomized PodCAST-PCI trial.
News
‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg
March 16, 2021
“[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured properly.”
News
Inpatient sodium imbalances linked to adverse COVID-19 outcomes
March 11, 2021
Hypernatremia during hospitalization was associated with increased COVID-19 mortality and to a greater need for ventilatory support.
News
CDC data strengthen link between obesity and severe COVID
March 9, 2021
Progressively intensive management of COVID-19 might be needed for patients with more severe obesity.
News
DOACs offered after heart valve surgery despite absence of data
March 9, 2021
Use of direct oral anticoagulants following heart valve surgery is occurring despite relative contraindications, but expert doubts its clinical significance.
News
RECOVERY trial of COVID-19 treatments stops colchicine arm
March 8, 2021
Recruitment was halted for lack of efficacy in patients hospitalized with the disease.
News
MIS-C follow-up proves challenging across pediatric hospitals
March 8, 2021
First came the challenge of figuring out the best treatment regimen for patients with MIS-C. Then physicians had to think about follow-up.
News
Heart failure redefined with new classifications, staging
March 8, 2021
Heart failure terminology gets a landmark reno, with a new universal definition, revised stages of development and progression, and updated LVEF classifications.
News
Late-window stroke thrombolysis not linked to clot migration
March 3, 2021
This is the first randomized controlled study to assess the effect of thrombolysis on clot migration and accessibility in an extended time window.
News
Thirteen percent of patients with type 2 diabetes have major ECG abnormalities
March 2, 2021
ECGs from more than 8,000 Dutch patients with type 2 diabetes, most without known cardiovascular disease, show that major abnormalities are not unusual.